Publicaciones en las que colabora con José Martínez Lanao (23)

2022

  1. Physiologically Based Pharmacokinetic (PBPK) Model of Gold Nanoparticle-Based Drug Delivery System for Stavudine Biodistribution

    Pharmaceutics, Vol. 14, Núm. 2

2021

  1. Advances in Exosomes-Based Drug Delivery Systems

    Macromolecular Bioscience, Vol. 21, Núm. 1

  2. Cell-based drug delivery platforms

    Pharmaceutics

  3. Recent advances in functionalized nanomaterials for the diagnosis and treatment of bacterial infections

    Materials Science and Engineering C, Vol. 121

2020

  1. Targeting of Hepatic Macrophages by Therapeutic Nanoparticles

    Frontiers in immunology, Vol. 11, pp. 218

2018

  1. Incorporación de agentes anti-infecciosos en nanopartículas metálicas de oro y chitosan

    Farmajournal, Vol. 3, Núm. 2, pp. 53-61

  2. Nanoparticles for signaling in biodiagnosis and treatment of infectious diseases

    International Journal of Molecular Sciences, Vol. 19, Núm. 6

2017

  1. Applications of Metallic Nanoparticles in Antimicrobial Therapy

    Antimicrobial Nanoarchitectonics: From Synthesis to Applications (Elsevier Inc.), pp. 411-444

  2. Gold Nanocarriers for Macrophage-Targeted Therapy of Human Immunodeficiency Virus

    Macromolecular Bioscience, Vol. 17, Núm. 3

2016

  1. Current applications of nanoparticles in infectious diseases

    Journal of Controlled Release, Vol. 224, pp. 86-102

2013

  1. Tratado general de biofarmacia y farmacocinética: Volumen I: LADME. Análisis farmacocinético. Biodisponibilidad y bioequivalencia

    Síntesis

2012

  1. Cell-based drug-delivery platforms

    Therapeutic Delivery, Vol. 3, Núm. 1, pp. 25-41

2009

  1. Increasing the selectivity of amikacin in rat peritoneal macrophages using carrier erythrocytes

    European Journal of Pharmaceutical Sciences, Vol. 38, Núm. 4, pp. 320-324

2008

  1. Delivery systems to increase the selectivity of antibiotics in phagocytic cells

    Journal of Controlled Release, Vol. 125, Núm. 3, pp. 210-227

2007

  1. Recent advances in delivery systems for anti-HIV1 therapy

    Journal of Drug Targeting, Vol. 15, Núm. 1, pp. 21-36

2005

  1. Comparative study of the disposition of levofloxacin, netilmicin and cefepime in the isolated rat lung

    Journal of Pharmacy and Pharmacology, Vol. 57, Núm. 7, pp. 861-867

  2. Influence of flow rate on the disposition of levofloxacin and netilmicin in the isolated rat lung

    European Journal of Pharmaceutical Sciences, Vol. 24, Núm. 4, pp. 325-332

2003

  1. Estudio comparativo de la distribución de levofloxacino y netilmicina en pulmón aislado de rata. Influencia del flujo de perfusión

    VI Congreso de la Sociedad Española de Farmacia Industrial y Galénica. 3ª Jornadas de Tecnología Farmecéutica. Granada, 9-11 de febrero de 2003.: Libro de Comunicaciones (Comares), pp. 361-364

2002

  1. In vitro study of experimental factors affecting the microdialysis results

    Analytica Chimica Acta, Vol. 459, Núm. 1, pp. 143-150

1998

  1. A comparative study of ofloxacin and ciprofloxacin erythrocyte distribution

    Biopharmaceutics and Drug Disposition, Vol. 19, Núm. 2, pp. 71-77